A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
Abstract The current chemotherapy treatments for liver cancer have shown limited effectiveness. Therefore, there is an urgent need to develop new drugs to combat this disease more effectively. This study reports synthesis of cobalt oxide nanoparticles coated with glucose, and conjugated with Ellagic...
Saved in:
Main Authors: | Ayda Mahmoudi, Vajiheh Zarrin Pour, Ali Salehzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85312-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ellagic acid ameliorates cisplatin-induced acute kidney injury by regulating inflammation and SIRT6/TNF-α signaling
by: Yuqi Gao, et al.
Published: (2023-11-01) -
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
by: Al-Shar’i Nizar A., et al.
Published: (2021-03-01) -
Pharmacokinetics study of a supersaturatable self-microemulsifying drug delivery system for ellagic acid by UHPLC-Q-TOF-MS
by: Wang Jinglong, et al.
Published: (2021-12-01) -
Ellagic Acid from <i>Geranium thunbergii</i> and Antimalarial Activity of Korean Medicinal Plants
by: Hojong Jun, et al.
Published: (2025-01-01) -
A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease
by: Sara Mighani, et al.
Published: (2025-01-01)